首页 › 股票 › PHAT

PHAT — PHATHOM PHARMACEUTICALS INC

申报持仓市值$1.00B
持有基金数(最新)320
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)171
机构持仓市值$823.49M · 75.96M 股
新建/增持/减仓/清仓24 / 61 / 52 / 34 · 更新于 2026-11-14
前五大/前十大集中度42.1% / 60.0%
机构整体持仓变动 增持 +1.4% (+977.09K 股)
机构持仓市值变动 下降 -1.0%

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 171 家机构在其最新 13F 申报中持有 PHAT(PHATHOM PHARMACEUTICALS INC),合计申报市值 $823.49M,对应 75.96M 股。按股数计算较上季度增持 1.4%(+977.09K 股),申报市值环比下降 1.0%。持仓集中度较高:前五大持有人占申报市值的 42.1%,前十大的集中度为 60.0%。

与上一季度相比,24 家新建仓位、61 家加仓、52 家减仓、34 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

PHATHOM PHARMACEUTICALS INC(PHAT)的主要机构持有人包括 Frazier Life Sciences Management, L.P.、Medicxi Ventures Management (Jersey) Ltd、Vanguard Group,按 13F 申报市值在本页 320 家持有人中排名居前。

PHAT 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 110 39.04M $281.68M -0.1%
Q2 2026 171 75.96M $823.49M +1.4%
Q1 2026 181 73.32M $814.14M +9.6%
Q4 2025 177 64.01M $1.06B -9.2%
Q3 2025 138 68.33M $803.92M +10.1%
Q2 2025 125 60.81M $582.88M +8.2%
Q1 2025 139 64.87M $406.49M +2.9%
Q4 2024 143 66.38M $538.60M +1.4%

表内 8 个季度中,机构持股合计减少 41%(Q4 2024 → Q3 2026);单季变动最大的是 Q3 2025(+10.1%)。

前 25 大机构持仓人(Q3 2026) — 25 家基金

基金股数金额组合权重变化
Medicxi Ventures Management (Jersey) Ltd 历史持仓 7.46M $54.49M 43.02% 持有
BlackRock Inc 5.25M $38.30M 0.00% 增持
Carlyle Group Inc. 历史持仓 3.50M $25.53M 0.30% 持有
WASATCH ADVISORS LP 2.94M $21.48M 0.16% 增持
VANGUARD CAPITAL MANAGEMENT LLC 2.74M $19.97M 0.00% 增持
GW&K Investment Management, LLC 2.13M $15.54M 0.13% 减持
STATE STREET CORP 2.00M $14.58M 0.00% 增持
Catalys Pacific, LLC 历史持仓 1.88M $13.74M 6.55% 增持
Franklin Resources 2.41M $13.67M 0.00% 增持
Geode Capital Management 1.33M $9.74M 0.00% 增持
Propel Bio Management, LLC 历史持仓 1.11M $8.07M 4.28% 增持
Ensign Peak Advisors, Inc 813.98K $5.94M 0.01% 减持
VANGUARD PORTFOLIO MANAGEMENT LLC 679.32K $4.96M 0.00% 减持
VANGUARD FIDUCIARY TRUST CO 394.31K $2.88M 0.00% 增持
UBS Group AG 376.38K $2.75M 0.00% 增持
Jones Hill Capital LP 历史持仓 276.83K $2.02M 0.34% 增持
JPMorgan Chase & Co 273.77K $2.01M 0.00% 减持
Simplify Asset Management Inc. 249.27K $1.82M 0.03% 持有
BNP PARIBAS FINANCIAL MARKETS 196.29K $1.43M 0.00% 增持
NewEdge Advisors, LLC 189.19K $1.38M 0.00% 减持
Stonepine Capital Management, LLC 历史持仓 100.00K $1.25M 0.96% 增持
Virtus Investment Advisers, LLC 162.54K $1.19M 0.26% 增持
BNY Mellon 156.31K $1.14M 0.00% 增持
Squarepoint Ops LLC 140.60K $1.03M 0.00% 增持
Nuveen, LLC 134.12K $979.05K 0.00% 增持

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 25 家基金

基金股数金额组合权重变化
Frazier Life Sciences Management, L.P. 历史持仓 12.47M $135.26M 2.95% 持有
Medicxi Ventures Management (Jersey) Ltd 历史持仓 7.46M $80.99M 45.65% 持有
BlackRock Inc 4.53M $49.10M 0.00% 增持
Invesco Ltd 4.03M $43.72M 0.00% 减持
Carlyle Group Inc. 历史持仓 3.50M $37.94M 0.38% 持有
Millennium Management 3.38M $36.63M 0.01% 减持
MILLENNIUM MANAGEMENT LLC 3.38M $36.63M 0.05% 减持
VANGUARD CAPITAL MANAGEMENT LLC 2.66M $28.83M 0.00% 增持
GW&K Investment Management, LLC 2.17M $23.51M 0.18% 增持
Franklin Resources 1.97M $21.38M 0.01% 增持
NEA Management Company, LLC 历史持仓 1.96M $21.27M 1.34% 持有
683 Capital Management, LLC 历史持仓 1.85M $20.07M 1.07% 持有
Goldman Sachs Group 1.78M $19.29M 0.01% 增持
Catalys Pacific, LLC 历史持仓 1.49M $16.21M 7.06% 持有
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 1.46M $15.87M 0.03% 增持
GEODE CAPITAL MANAGEMENT, LLC 1.32M $14.28M 0.00% 新进
Geode Capital Management 1.32M $14.28M 0.00% 减持
WASATCH ADVISORS LP 1.31M $14.18M 0.09% 减持
Ensign Peak Advisors, Inc 1.05M $11.41M 0.02% 减持
Propel Bio Management, LLC 历史持仓 1.05M $11.40M 5.96% 增持
Point72 Asset Management 1.02M $11.09M 0.04% 新进
VANGUARD PORTFOLIO MANAGEMENT LLC 796.63K $8.64M 0.00% 增持
SummitTX Capital, L.P. 789.55K $8.57M 0.28% 减持
HSBC HOLDINGS PLC 709.70K $7.70M 0.01% 新进
Marshall Wace 666.09K $7.23M 0.01% 减持

Q1 2026 — 25 家基金

基金股数金额组合权重变化
Frazier Life Sciences Management, L.P. 历史持仓 12.47M $138.50M 3.56% 持有
Medicxi Ventures Management (Jersey) Ltd 历史持仓 7.46M $82.93M 8.45% 持有
Invesco Ltd 4.32M $48.02M 0.01% 增持
BlackRock Inc 4.06M $45.13M 0.00% 增持
Millennium Management 4.02M $44.69M 0.02% 增持
MILLENNIUM MANAGEMENT LLC 4.02M $44.69M 0.06% 增持
Carlyle Group Inc. 历史持仓 3.50M $38.85M 0.37% 持有
VANGUARD CAPITAL MANAGEMENT LLC 2.58M $28.70M 0.00% 新进
NEA Management Company, LLC 历史持仓 1.96M $21.78M 1.24% 持有
683 Capital Management, LLC 历史持仓 1.85M $20.55M 1.29% 增持
Ensign Peak Advisors, Inc 1.63M $18.08M 0.03% 减持
Catalys Pacific, LLC 历史持仓 1.49M $16.60M 7.19% 增持
GW&K Investment Management, LLC 1.42M $15.79M 0.14% 增持
STATE STREET CORP 1.39M $15.41M 0.00% 增持
WASATCH ADVISORS LP 1.34M $14.90M 0.10% 增持
Geode Capital Management 1.33M $14.76M 0.00% 增持
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 1.21M $13.39M 0.02% 新进
SummitTX Capital, L.P. 995.88K $11.06M 0.41% 增持
Franklin Resources 994.50K $11.05M 0.00% 新进
PERCEPTIVE ADVISORS LLC 925.00K $10.28M 0.22% 新进
Marshall Wace 860.69K $9.56M 0.01% 新进
Propel Bio Management, LLC 历史持仓 841.27K $9.35M 5.90% 增持
VANGUARD PORTFOLIO MANAGEMENT LLC 666.03K $7.40M 0.00% 新进
Goldman Sachs Group 626.20K $6.96M 0.00% 增持
EcoR1 Capital, LLC 历史持仓 625.00K $6.94M 0.33% 新进

Q4 2025 — 25 家基金

基金股数金额组合权重变化
Frazier Life Sciences Management, L.P. 历史持仓 12.47M $206.82M 5.55% 持有
Medicxi Ventures Management (Jersey) Ltd 历史持仓 7.46M $123.84M 14.83% 持有
Invesco Ltd 3.92M $65.04M 0.01% 增持
BlackRock Inc 3.56M $58.99M 0.00% 增持
Carlyle Group Inc. 历史持仓 3.50M $57.98M 0.43% 持有
Vanguard Group 3.18M $52.71M 0.00% 减持
Ensign Peak Advisors, Inc 2.35M $39.02M 0.07% 减持
Millennium Management 2.08M $34.54M 0.01% 减持
MILLENNIUM MANAGEMENT LLC 2.08M $34.54M 0.05% 减持
NEA Management Company, LLC 历史持仓 1.96M $32.52M 1.66% 持有
683 Capital Management, LLC 历史持仓 1.78M $29.61M 1.49% 减持
Catalys Pacific, LLC 历史持仓 1.43M $23.71M 7.63% 增持
WASATCH ADVISORS LP 1.33M $22.09M 0.13% 减持
GW&K Investment Management, LLC 1.31M $21.68M 0.19% 增持
STATE STREET CORP 1.15M $19.07M 0.00% 增持
Geode Capital Management 1.07M $17.81M 0.00% 减持
Propel Bio Management, LLC 历史持仓 740.92K $12.29M 10.49% 增持
Catalio Capital Management, LP 699.00K $11.60M 2.05% 减持
Divisadero Street Capital Management, LP 662.31K $10.99M 0.65% 新进
Moore Capital Management 600.00K $9.95M 0.19% 持有
SummitTX Capital, L.P. 517.82K $8.59M 0.26% 增持
Caption Management, LLC 486.30K $8.07M 0.18% 减持
Charles Schwab Investment Management 397.91K $6.60M 0.00% 增持
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 397.91K $6.60M 0.00% 增持
NEXT CENTURY GROWTH INVESTORS LLC 393.77K $6.53M 0.45% 新进

Q3 2025 — 25 家基金

基金股数金额组合权重变化
Frazier Life Sciences Management, L.P. 历史持仓 12.47M $146.73M 4.40% 持有
Medicxi Ventures Management (Jersey) Ltd 历史持仓 7.46M $87.86M 11.80% 持有
MILLENNIUM MANAGEMENT LLC 5.08M $59.81M 0.10% 增持
Millennium Management 5.08M $59.81M 0.03% 增持
Invesco Ltd 3.86M $45.49M 0.01% 减持
Carlyle Group Inc. 历史持仓 3.50M $41.05M 0.95% 持有
BlackRock Inc 3.40M $40.05M 0.00% 增持
Vanguard Group 3.22M $37.85M 0.00% 增持
Ensign Peak Advisors, Inc 2.50M $29.46M 0.05% 减持
NEA Management Company, LLC 历史持仓 1.96M $23.07M 1.27% 持有
683 Capital Management, LLC 历史持仓 1.82M $21.43M 1.34% 减持
WASATCH ADVISORS LP 1.54M $18.09M 0.10% 增持
Catalys Pacific, LLC 历史持仓 1.17M $13.74M 3.91% 持有
GW&K Investment Management, LLC 1.14M $13.47M 0.12% 增持
Catalio Capital Management, LP 1.13M $13.28M 2.46% 增持
Geode Capital Management 1.09M $12.82M 0.00% 增持
STATE STREET CORP 1.05M $12.40M 0.00% 增持
Caption Management, LLC 1.00M $11.77M 0.26% 增持
Moore Capital Management 600.00K $7.06M 0.14% 持有
AMERIPRISE FINANCIAL INC 554.59K $6.53M 0.00% 增持
Propel Bio Management, LLC 历史持仓 552.93K $6.51M 6.51% 减持
AIGH Capital Management LLC 429.00K $5.05M 1.65% 新进
StepStone Group LP 历史持仓 422.08K $4.97M 2.34% 持有
SummitTX Capital, L.P. 385.97K $4.54M 0.20% 新进
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 365.90K $4.31M 0.00% 增持

Q2 2025 — 25 家基金

基金股数金额组合权重变化
Frazier Life Sciences Management, L.P. 历史持仓 12.47M $119.55M 4.78% 增持
Medicxi Ventures Management (Jersey) Ltd 历史持仓 7.46M $71.59M 16.75% 持有
Invesco Ltd 4.14M $39.70M 0.01% 增持
Carlyle Group Inc. 历史持仓 3.50M $33.53M 0.67% 持有
BlackRock Inc 3.32M $31.79M 0.00% 持有
Vanguard Group 2.79M $26.73M 0.00% 持有
Ensign Peak Advisors, Inc 2.52M $24.17M 0.04% 持有
MILLENNIUM MANAGEMENT LLC 2.25M $21.58M 0.04% 增持
Millennium Management 2.25M $21.58M 0.01% 增持
683 Capital Management, LLC 历史持仓 2.10M $20.19M 1.65% 增持
NEA Management Company, LLC 历史持仓 1.96M $18.80M 1.42% 持有
WASATCH ADVISORS LP 1.46M $14.02M 0.07% 减持
Catalys Pacific, LLC 历史持仓 1.17M $11.19M 8.50% 持有
Geode Capital Management 1.07M $10.26M 0.00% 增持
Avidity Partners Management LP 历史持仓 1.06M $10.21M 2.05% 增持
GW&K Investment Management, LLC 1.05M $10.05M 0.09% 减持
Propel Bio Management, LLC 历史持仓 922.93K $8.85M 10.80% 减持
STATE STREET CORP 849.42K $8.15M 0.00% 减持
Catalio Capital Management, LP 672.29K $6.45M 1.35% 新进
Moore Capital Management 600.00K $5.75M 0.11% 新进
Simplify Asset Management Inc. 521.93K $5.01M 0.25% 减持
Citigroup Inc 517.25K $4.96M 0.01% 减持
StepStone Group LP 历史持仓 422.08K $4.05M 8.03% 持有
UBS Group AG 419.47K $4.02M 0.00% 减持
Caption Management, LLC 380.10K $3.65M 0.11% 新进

查看全部 320 家持有基金 →

新建仓(Q2 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Medicxi Ventures Management (Jersey) Ltd 7.46M 7.46M 7.46M 7.46M 7.46M 7.46M 7.46M 7.46M 7.46M 7.46M 7.46M 3.76M 3.76M — — — — — — —
BlackRock Inc 5.25M 4.53M 4.06M 3.56M 3.40M 3.32M 3.32M 3.50M 3.12M — — — — — — — — — — —
Carlyle Group Inc. 3.50M 3.50M 3.50M 3.50M 3.50M 3.50M 3.50M 3.50M 3.50M 3.50M 3.50M 3.50M 3.50M — — — — — — —
WASATCH ADVISORS LP 2.94M 1.31M 1.34M 1.33M 1.54M 1.46M 1.70M 1.56M 246.94K — — — — — — — — — — —
VANGUARD CAPITAL MANAGEMENT LLC 2.74M 2.66M 2.58M — — — — — — — — — — — — — — — — —
GW&K Investment Management, LLC 2.13M 2.17M 1.42M 1.31M 1.14M 1.05M 1.10M 1.10M 1.13M 600.44K 568.03K 561.49K 577.45K — — — — — — —
STATE STREET CORP 2.00M — 1.39M 1.15M 1.05M 849.42K 901.35K 1.04M 922.79K 785.25K 717.20K 687.84K 667.60K — — — — — — —
Catalys Pacific, LLC 1.88M 1.49M 1.49M 1.43M 1.17M 1.17M 1.17M 1.17M 1.12M 721.96K 721.96K 721.96K — — — — — — — —
Franklin Resources 2.41M 1.97M 994.50K — — — — — — — — — — — — — — — — —
Geode Capital Management 1.33M 1.32M 1.33M 1.07M 1.09M 1.07M 1.02M 1.02M 862.92K 806.05K 751.38K 735.27K 682.57K 490.12K 448.61K 435.04K 402.29K 346.94K 313.82K 293.20K
Propel Bio Management, LLC 1.11M 1.05M 841.27K 740.92K 552.93K 922.93K 1.13M 989.93K 869.93K 869.93K 869.93K 443.05K — — — — — — — —
Ensign Peak Advisors, Inc 813.98K 1.05M 1.63M 2.35M 2.50M 2.52M 2.51M 2.53M 2.58M 2.24M 2.28M 2.28M 1.73M — — — — — — —
VANGUARD PORTFOLIO MANAGEMENT LLC 679.32K 796.63K 666.03K — — — — — — — — — — — — — — — — —
VANGUARD FIDUCIARY TRUST CO 394.31K 354.57K 338.71K — — — — — — — — — — — — — — — — —
UBS Group AG 376.38K 204.57K 360.37K 304.38K 338.36K 419.47K 707.58K 465.62K 71.94K 43.09K 49.92K 39.43K 33.70K 16.81K — 795 628 — — 1.33K
Jones Hill Capital LP 276.83K 161.49K — — — — — — — — — — — — — — — — — —
JPMorgan Chase & Co 273.77K 275.25K 287.43K 296.68K 136.95K 138.52K 137.39K 136.91K 135.43K 134.36K 138.45K 146.04K 144.76K 134.00K 114.79K 129.15K 171.37K 170.79K 175.56K 172.56K
Simplify Asset Management Inc. 249.27K 249.27K 262.39K 321.94K 321.94K 521.93K 681.93K 581.93K 521.93K 521.93K 521.93K 237.94K 237.94K — — — — — — —
BNP PARIBAS FINANCIAL MARKETS 196.29K 8.69K 11.33K 9.79K 8.83K 5.07K 2.95K 39.53K — — — — — — — — — — — —
NewEdge Advisors, LLC 189.19K 203.96K 183.00K 200.82K 201.52K — — — — — — — — — — — — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold PHAT?

As of 2026-Q2, 171 institutional funds reported holding PHAT (PHATHOM PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $823.49M.

How many shares of PHAT do institutions own?

13F filers reported 75.96M shares of PHAT, worth $823.49M in aggregate at the end of 2026-Q2.

Is institutional ownership of PHAT rising or falling?

Share counts moved +1.4% versus the prior quarter — accumulation.

Who are the top institutional holders of PHAT?

The largest 13F holders are Frazier Life Sciences Management, L.P., Medicxi Ventures Management (Jersey) Ltd, Vanguard Group, JENNISON ASSOCIATES LLC, BlackRock Inc; the top 25 are ranked at the top of this page.

Who are the major shareholders of PHATHOM PHARMACEUTICALS INC?

The major shareholders of PHATHOM PHARMACEUTICALS INC (PHAT) by reported 13F value are Frazier Life Sciences Management, L.P., Medicxi Ventures Management (Jersey) Ltd, Vanguard Group, JENNISON ASSOCIATES LLC, BlackRock Inc, among 320 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 PHAT」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/PHAT/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →